These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 4592605)

  • 21. [Immunological phenomena in LCM virus-infected mice].
    Cihak J; Lehmann-Grube F; Cihak J
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):450-7. PubMed ID: 4154626
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice.
    Parker LM; Chused TM; Steinberg AD
    J Immunol; 1974 Jan; 112(1):285-92. PubMed ID: 4590823
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice.
    Welsh RM; Zinkernagel RM
    Nature; 1977 Aug; 268(5621):646-8. PubMed ID: 302419
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigenic differences between spleen-seeking and lymph node-seeking thymus cells.
    Schlesinger M; Shlomai-Korzash Z; Israèl E
    Eur J Immunol; 1973 Jun; 3(6):335-9. PubMed ID: 4543317
    [No Abstract]   [Full Text] [Related]  

  • 26. [New surface antigens on LCM virus-infected cells].
    Rutter G; Gschwender HH; Mannweiler K; Lehmann-Grube F
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):443-9. PubMed ID: 4154625
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunopathogenesis of LCM virus-induced uveitis: the role of T lymphocytes.
    Ticho U; Silverstein AM; Cole GA
    Invest Ophthalmol; 1974 Mar; 13(3):229-31. PubMed ID: 4591832
    [No Abstract]   [Full Text] [Related]  

  • 28. Course of lymphocytic choriomeningitis virus infection in young and aged mice.
    Anderlik P; Szeri I; Bános S; Radnai B
    Acta Microbiol Acad Sci Hung; 1975; 22(1):27-31. PubMed ID: 1111261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 30. Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex.
    Blanden RV; Doherty PC; Dunlop MB; Gardner ID; Zinkernagel RM; David CS
    Nature; 1975 Mar; 254(5497):269-70. PubMed ID: 1078719
    [No Abstract]   [Full Text] [Related]  

  • 31. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G; Lennox ES
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract]   [Full Text] [Related]  

  • 32. T-cell-mediated immunopathology in viral infections.
    Doherty PC; Zinkernagel RM
    Transplant Rev; 1974; 19(0):89-120. PubMed ID: 4601807
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.
    Zinkernagel RM; Doherty PC
    Nature; 1974 Oct; 251(5475):547-8. PubMed ID: 4547543
    [No Abstract]   [Full Text] [Related]  

  • 34. An antigenic determinant of cytotoxic lymphocytes.
    Sullivan KA; Berke G; Amos DB
    Transplantation; 1973 Oct; 16(4):388-91. PubMed ID: 4126790
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats.
    Zinkernagel RM; Althage A; Jensen FC
    J Immunol; 1977 Oct; 119(4):1242-7. PubMed ID: 408419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the immunoglobulin eluted from the glomeruli of mice chronically infected with lymphocytic choriomeningitis virus.
    Klein B; Hill C; Hoffsten PE
    J Immunol; 1977 Aug; 119(2):707-13. PubMed ID: 889613
    [No Abstract]   [Full Text] [Related]  

  • 37. On T-cell-mediated cytotoxicity.
    Golstein P; Blomgren H; Svedmyr EA; Wigzell H
    Transplant Proc; 1973 Dec; 5(4):1441-5. PubMed ID: 4204523
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation and effects of an anti-B cell serum.
    Kakiuchi T; Nariuchi H; Tamura N
    J Immunol; 1976 May; 116(5):1224-7. PubMed ID: 774977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus (SV 40) tumors in mice.
    Tevethia SS; Blasecki JW; Waneck G; Goldstein AL
    J Immunol; 1974 Nov; 113(5):1417-23. PubMed ID: 4371155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.